Literature DB >> 26247507

Effects of long-term administration of aspartame on biochemical indices, lipid profile and redox status of cellular system of male rats.

Oluwatosin A Adaramoye, Olubukola O Akanni.   

Abstract

BACKGROUND: Aspartame (N-L-α-aspartyl-L-phenylalanine-1-methyl ester) (ASP) is a synthetic sweetener used in foods and its safety remains controversial. The study was designed to investigate the effects of long-term administration of aspartame on redox status, lipid profile and biochemical indices in tissues of male Wistar rats.
METHODS: Rats were assigned into four groups and given distilled water (control), aspartame at doses of 15 mg/kg (ASP 1), 35 mg/kg (ASP 2) and 70 mg/kg (ASP 3) daily by oral gavage for consecutive 9 weeks.
RESULTS: Administration of ASP 2 and ASP 3 significantly increased the weight of liver and brain, and relative weight of liver of rats. Lipid peroxidation products significantly increased in the kidney, liver and brain of rats at all doses of ASP with concomitant depletion of antioxidant parameters, viz. glutathione-s-transferase, glutathione peroxidase, superoxide dismutase, catalase and reduced glutathione. Furthermore, ASP 2 and ASP 3 significantly increased the levels of gamma glutamyl transferase by 70% and 85%; alanine aminotransferase by 66% and 117%; aspartate aminotransferase by 21% and 48%; urea by 72% and 58% and conjugated bilirubin by 63% and 64%, respectively. Also, ASP 2 and ASP 3 significantly increased the levels of total cholesterol, triglycerides and low-density lipoprotein cholesterol in the rats. Histological findings showed that ASP 2 and ASP 3 caused cyto-architectural changes such as degeneration, monocytes infiltration and necrotic lesions in brain, kidney and liver of rats.
CONCLUSIONS: Aspartame may induce redox and lipid imbalance in rats via mechanism that involves oxidative stress and depletion of glutathione-dependent system.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26247507     DOI: 10.1515/jbcpp-2014-0130

Source DB:  PubMed          Journal:  J Basic Clin Physiol Pharmacol        ISSN: 0792-6855


  6 in total

1.  Aspartame and Soft Drink-Mediated Neurotoxicity in Rats: Implication of Oxidative Stress, Apoptotic Signaling Pathways, Electrolytes and Hormonal Levels.

Authors:  Mohamed A Lebda; Kadry M Sadek; Yasser S El-Sayed
Journal:  Metab Brain Dis       Date:  2017-06-28       Impact factor: 3.584

2.  Astrogliosis and decreased neural viability as consequences of early consumption of aspartame and acesulfame potassium in male Wistar rats.

Authors:  Anayelly Solis-Medina; José Jaime Martínez-Magaña; Valeria Quintanar-Jurado; Ileana Gallegos-Silva; Isela E Juárez-Rojop; Carlos Alfonso Tovilla-Zárate; Juan C Díaz-Zagoya; Yazmín Hernández-Díaz; Thelma Beatriz González-Castro; María Lilia López-Narváez; Alma Delia Genis-Mendoza; Humberto Nicolini
Journal:  Metab Brain Dis       Date:  2018-09-28       Impact factor: 3.584

3.  Dietary Additives and Supplements Revisited: The Fewer, the Safer for Liver and Gut Health.

Authors:  Rachel Golonka; Beng San Yeoh; Matam Vijay-Kumar
Journal:  Curr Pharmacol Rep       Date:  2019-06-10

Review 4.  Beverage consumption and paediatric NAFLD.

Authors:  Antonella Mosca; Claudia Della Corte; Maria Rita Sartorelli; Francesca Ferretti; Francesco Nicita; Andrea Vania; Valerio Nobili
Journal:  Eat Weight Disord       Date:  2016-08-26       Impact factor: 4.652

5.  Long-Term Aspartame Administration Leads to Fibrosis, Inflammasome Activation, and Gluconeogenesis Impairment in the Liver of Mice.

Authors:  Isabela A Finamor; Caroline A Bressan; Isabel Torres-Cuevas; Sergio Rius-Pérez; Marcelo da Veiga; Maria I Rocha; Maria A Pavanato; Salvador Pérez
Journal:  Biology (Basel)       Date:  2021-01-22

6.  The in vitro cytotoxic, genotoxic, and oxidative damage potentials of the oral artificial sweetener aspartame on cultured human blood cells

Authors:  Kenan Çadirci; Özlem Özdemir Tozlu; Hasan Türkez; Adil Mardinoğlu
Journal:  Turk J Med Sci       Date:  2020-04-09       Impact factor: 0.973

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.